Literature DB >> 17346607

Cox regression was used to compare the measurement error of two tests vs. a gold standard.

Gianni Virgili1, Mario Angi, Andrea Molinari, Veronica Casotto.   

Abstract

OBJECTIVE: The use of survival analysis has been proposed to compare the diagnostic performance of two tests. We expanded it to compare two tests with a gold standard simultaneously. STUDY DESIGN AND
SETTING: In this diagnostic study, the spherical equivalent component of refraction was measured with the PowerRefractor and the Canon R-50 autorefractor. The reference test was Canon R-50 autorefraction with cycloplegic blockage of accommodation. The error of the two index tests was compared with Cox regression analysis with robust standard error estimation to take into account repeated measures on the same subject. We evaluated 1,559 children aged 5-6 from 25 schools in three urban locations in Ecuador.
RESULTS: The main strength of survival analysis was that it does not assume a specific distribution of measurement errors, which were not normally distributed in this study. The proportional hazards assumption, a requirement of Cox regression, was met only after removal of the bias of each test. When this was done, noncycloplegic autorefraction was better than the PowerRefractor regardless of the magnitude and direction of the error.
CONCLUSION: The potential of Cox regression can be applied to diagnostic studies that compare more tests with a gold standard.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346607     DOI: 10.1016/j.jclinepi.2006.07.013

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  2 in total

1.  Comparison of the Retinomax and Palm-AR Auto-Refractors: a pilot study.

Authors:  Elise Ciner; Ashanti Carter; Gui-Shuang Ying; Maureen Maguire; Marjean Taylor Kulp
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

2.  Measuring refraction in adults in epidemiological studies.

Authors:  Elizabeth M Krantz; Karen J Cruickshanks; Barbara E K Klein; Ronald Klein; Guan-Hua Huang; F Javier Nieto
Journal:  Arch Ophthalmol       Date:  2010-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.